Diabetes and Endocrinology Clinical Trials
| Name | Locations | |
|---|---|---|
| Diabetes Mobile Web Application: Evaluating the Clinical Impact of a PCP Developed Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes. | RH | Learn More |
Heart/Cardiology Clinical Trials
| Name | Locations | |
|---|---|---|
| OPTIMIZER Smart: OPTIMIZER Smart Post-Approval Study | RH | Learn More |
| EVOLVE-MI: Myocardial Infarction: A Pragmatic Randomized Multicenter Trial of EVOLocumab Administered Very Early to Reduce the Risk of Cardiovascular Events in Patients Hospitalized With Acute Myocardial Infarction | RH | Learn More |
Infectious Disease Clinical Trials
| Name | Locations | |
|---|---|---|
| Babesia Infection: Evaluation of Immune Response and Antigen Signature of Patients with Babesia Infection in Pennsylvania with the Aim of Developing a Rapid Diagnostic Testing | RH | Learn More |
Neurology Clinical Trials
| Name | Locations | |
|---|---|---|
| REMODEL - Multiple Sclerosis: A randomized, double-blind, double-dummy, parallel-group study, comparing the efficacy and safety of remibrutinib versus teriflunomide in participants with relapsing multiple sclerosis, followed by extended treatment with open-label remibrutinib. | RH | Learn More |
| EMD – Multiple Sclerosis AGING Study: A multi-center, observational study to characterize the clinical course in a real world, US cohort of patients with relapsing Multiple Sclerosis of advanced age (> 50 years) treated with Cladribine tablets (AGING Study). | RH | Learn More |
Prostate, Kidney, and Urologic Clinical Trials
| Name | Locations | |
|---|---|---|
| E.mbrace - Extraintestinal e.Coli Infection: Randomized, Double-blind, Placebo-controlled, Multicenter Phase 3 Study to Assess the Efficacy, Safety And Immunogenicity of Vaccination With ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia coli Disease in Adults Aged 60 Years And Older with a History of Urinary Tract Infection in the Past 2 Years. | RH | Learn More |
Research Location
Clinical Trials Office at Reading Hospital
The Clinical Trials Office (CTO), located in the Doctors Office Building (DOB) at Reading Hospital, assists in all aspects of conducting research by providing regulatory, contractual, financial, and operational support for each research project at all of our clinical trials sites; both oncology and non-oncology research. Additionally the CTO conducts Phase II-IV non-oncology research and provides the latest and greatest clinical trial opportunities for the surrounding communities collaborating with Pharmaceutical sponsors, non-pharmaceutical sponsors, investigator-initiated projects and engages in supporting grant opportunities. Research staff are trained, experienced, and certified in conducting many different types of clinical trials and work with a variety of investigators from diverse specialties. For more information, please contact the CTO at 484-628-8585.
Services Offered:
- Centralized trial management
- Extensive experience in pharmaceutical and medical device trials
- Diverse inpatient and outpatient populations
- Expert oversight of clinical trial conduct
- Professional, experienced clinical research coordinators
- Physician investigators in most therapeutic areas or specialties
- Clinical Trial Management System (CTMS)
- Electronic regulatory document platform
- Subject recruitment and screening
- Strict compliance with FDA and good clinical practice standards
- Complete financial and administrative management
- Prompt review and execution of contracts
- Dedicated, experienced research pharmacists